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ABSTRACT
RNA and DNA guanine-rich sequences can adopt
unusual structures called Guanine quadruplexes
(G4). A quadruplex-prone RNA sequence is present
at the 50-end of the 451-nt-long RNA component of
telomerase, hTERC. As this quadruplex may inter-
fere with P1 helix formation, a key structural
element for this RNA, we are seeking molecules
that would alter this RNA duplex–quadruplex equi-
librium. In this work, we present a fluorescence-
based test designed to identify G4 ligands specific
for the hTERC G-rich motif and that can prevent P1
helix formation. From an initial panel of 169 different
molecules, 11 were found to be excellent P1 duplex
inhibitors. Interestingly, some of the compounds
not only exhibit a strong selectivity for quadruplexes
over duplexes, but also demonstrated a prefer-
ence for G4–RNA over all other quadruplexes. This
test may easily be adapted to almost any
quadruplex-forming sequence and converted into
HTS format.
INTRODUCTION
Guanine-rich sequences can adopt unusual structures
called Guanine quadruplexes (G4) based on stacked
guanine quartets (1). The human genome possesses
number of sequences prone to adopt such structures, as
for example in telomeric repeats, in several oncogenic pro-
moters, in ribosomal DNA and in the immunoglobulin
switch region. Key biological processes could be affected
by the formation of these structures (2,3). Furthermore,
formation of G4 has been evidenced in vivo in ciliate
telomeres (4), during G-rich sequence transcription
(G-loop) (5) and for pilin antigenic variation in Neisseria
gonorrhoeae (6).
Quadruplex formation is not limited to DNA sequences
and recent studies illustrated the importance of
quadruplexes at the RNA level such as hTERT splicing
(7), N-RAS 50UTR (8), prokaryotic translation start (9)
and TERRA (10).
A number of pathways potentially link quadruplex for-
mation (at the DNA or RNA level) and telomere mainten-
ance. Indeed, G4 formation has been evidenced for the
G-rich strand of telomeric repeats and could therefore
affect telomere elongation by telomerase (11–13), the
binding of other telomeric factors like hPOT1 (14). G4 for-
mation by the telomeric repeats could also affect general
telomere replication (15,16). TERRA, the RNA transcript
corresponding to the G-rich strand (17) has been proposed
to be involved in telomere function regulation (18) and can
form some very stable G4 (10,19). There are G4 prone se-
quences in the mRNA for the catalytic subunit of telomer-
ase (hTERT) which have been proposed to affect hTERT
splicing upon G4 ligand exposure (7). Finally, G4 forma-
tion has been reported in c-MYC (20) and hTERT (21,22)
promotersandthusG4ligandscouldaffecthTERTexpres-
sion and thus telomerase activity.
An evolutionary conserved quadruplex-prone RNA
sequence is also present at the 50-end of the RNA compo-
nent of telomerase, called hTERC (or hTR) in humans
(23). In a previous work, we demonstrated that oligo-
nucleotides mimicking the 50 of hTERC can form a G4
and that this could interfere with secondary structure, in-
hibiting the formation of a local RNA double helix called
P1 (23). In principle, the ability of hTERC to form a
quadruplex could therefore represent a new mechanism
of action to account for the telomeric effects of G4
ligands. This prompted us to study in more details the
implication of G4 formation in hTERC.
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on telomerase activity or biogenesis, we need to identify
G4 ligands that are speciﬁc for the G4 formed in hTERC.
In this work, we present a ﬂuorescence-based test designed
to identify G4 ligands speciﬁc for the G4 of hTERC and
that can prevent P1 helix formation. As a starting pool of
potential ligands, we used a library of compounds already
tested in the laboratory, which are mainly known telomer-
ic G4 DNA ligands. We choose to start with a library of
known G4 ligands as:
(i) we anticipated positive hits despite a small library
side;
(ii) we had some experience with these compounds;
(iii) afﬁnity for this quadruplex could be compared with
other targets;
(iv) these molecules have different scaffold and charges
and somewhat represent our current level of know-
ledge concerning the recognition of G-quadruplex;
and
(v) some of the compounds are commercially available
or may be easily obtained, and implementation
of a pilot assay in another lab is relatively
straigthforward.
This test relies on a duplex–quadruplex competition: com-
pounds that stabilize G4 RNA should inhibit hybridiza-
tion of the guanine-rich RNA to its complementary
sequence. The system chosen here closely matches the
biological situation, as the RNA–RNA duplex matches
the P1 helix of hTERC. Compounds that inhibit P1
helix formation are then tested for bona ﬁde RNA G4
binding.
MATERIALS AND METHODS
Oligonucleotides
Fluorescently labelled oligonucleotides (F22, F22m, 37Q
and 37Qm32) were purchased from IBA (Go ¨ ttingen,
Germany, RNA HPLC grade, 200nmol scale).
F22: 6FAM-50-UGGCCCGUUCGCCCCUCCCGGG-30
F22m: 6FAM-50-UGGCCCGUUCGCUUCUCUCGGG-30
37Q: 50-GGGUUGCGGAGGGUGGGCCUGGGAGGGGUGGUGG
CCA-30-BHQ1
37Qm32: 50-GAGUUGCGAAGAGUGAGCCUGAGAGAAGUGA
UGGCCA-30-BHQ1
Non-ﬂuorescent oligonucleotides were purchased on the
200nmol scale from IBA (HPLC grade) or Eurogentec
(Seraing, Belgium, Oligold grade). Unmodiﬁed sequences
used for competition experiment are reported in
Supplementary Table S1.
Chemicals
The ligands were taken from the in house ligand library
that we previously used mainly to identify telomeric
G4 ligands. These ligands were gifts or collabor-
ation products from many chemistry laboratories:
P. Mailliet (Sanoﬁ-Aventis, Vitry sur Seine, France),
M.P. Teulade-Fichou (Institut Curie, Orsay, France),
S. Neidle (School of Pharmacy, London, UK),
K. Shin-ya (University of Tokyo, Tokyo, Japan),
G. Pratviel (Laboratoire de Chimie de Coordination,
Toulouse, France), F. Gue ´ ritte (ICSN, Gif sur Yvette,
France), T.C. Chang (Institute of Atomic and Molecular
Sciences, Taiwan, ROC) and M. Stevens (School of
Pharmaceutical Sciences, University of Nottingam, UK).
We also included a family of crown-shape ligands
developed by C. Ferroud (CNAM, Paris, France).
Porphyrin derivatives were purchased from Frontier
Scientiﬁc (Logan, Utah, USA) and stock solutions
were prepared at 10mM in water. MST-312 and
PIPER were purchased from Calbiochem and resus-
pended at 10 and 2mM, respectively, in DMSO. For
all other ligands, 1–4mM DMSO stock solutions were
used. Cacodylic acid, KCl, LiOH and LiCl were from
Sigma.
Fluorescent test
For the screening test, the ﬂuorescent oligonucleotide
(F22) alone or in the presence of the complementary
strand (37Q) was incubated at 50nM in 20mM Lithium
cacodylate (pH 7.2) supplemented with 1mM KCl and
99mM LiCl. When present, 37Q was added in slight
molar excess (i.e. 75nM). After a simple annealing pro-
cedure (95 C, 150 then cool down to 40 Ca t1  C/min),
22.5ml of the ﬂuorescent mix were distributed into
96-well qPCR plates (Stratagene) containing 2.5mlo f
either a 10mM solution of ligand (giving a ﬁnal ligand
concentration of 1mM) or 1% DMSO (giving a ﬁnal con-
centration of 0.1%). After centrifugation, the plate was
transferred to a real-time thermal cycler (Mx3000p,
Stratagene). Data acquisition proceeds using the FAM
channel and in the following order (Supplementary
Figure S1):
Step 1: 30 steps of 1min at 37 C with a reading at the
end of each step.
Step 2: 15 steps of 1min at 95 C with a reading at the
end of each step.
Step 3: 31 steps of 1min from 95 Ct o3 7  C with a tem-
perature decrease of 2 C and a reading at the end of
each step.
After each ‘qPCR’ experiment, plates were read using a
ﬂuorescent imaging system (Typhoon 9410) using a
488-nm excitation wavelength and a 520BP40-emission
ﬁlter, with a 600-V PMT gain and a+3-mm focus setting.
Data analysis
Data from the qPCR apparatus were exported as text ﬁle
and processed with Microsoft Excel. No ligand effect was
observed during isothermal data acquisition at 37 C
(Step 1) and thus only data from Step 3 were analyzed.
For each well, ﬂuorescent intensity reading at 37 C after
the ‘in machine’ annealing (IF
37) was normalized with the
ﬂuorescent intensity reading corresponding dissociated
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82) of the same well to compensate for
well-to-well ﬂuorescence variations. In order to evaluate
the ability of a given ligand (X) to prevent duplex forma-
tion, we deﬁned a ligand efﬁcacy (Efﬁ) corresponding to
the fraction of unformed duplex, using normalized ﬂuor-
escence (NF=IF
37/IF
82) reading from wells containing the
ﬂuorescent oligonucleotide alone (F22) and wells contain-
ing the quenched duplex (F22+37Q) in the absence of
ligand.
Effi X ðÞ ¼
NF F22+37Q+X ðÞ   NF F22+37Q ðÞ ½ 
NF F22 ðÞ   NF F22+37Q ðÞ ½ 
Using this parameter, a good ligand that totally
prevents duplex formation will have an Efﬁ of 1 and a
poor ligand an Efﬁ of 0 (Supplementary Figure S3).
Slightly negative Efﬁ value are within the noise limits of
the system while more negative Efﬁ value might indicate a
conformational change of the duplex induced by the
ligand or a strong ﬂuorescence quenching of the FAM.
In both cases such molecules are unlikely to be false
negative compounds.
Quality of each plate was also assessed by computing a
Z0 factor (24), an estimator that take into account the
distribution of the minima and maxima value of the
plate and also the difference between these maxima and
minima. In our case, minima were associated with duplex
state controls (F22+37Q) and maxima with single-
stranded state controls (F22). Most plates contained
quadruplicates of the F22 alone and the F22+37Q wells
used for Efﬁ and Z0 calculation. Dissociation step data
(Step 2) and temperature proﬁle data from Step 3 were
used to assess quality of starting material and duplex for-
mation, respectively.
For experiments in the presence of competitors, a com-
petitor efﬁcacy (C_Efﬁ) of the competitor Y for the ligand
X was deﬁne using the following formula:
C_Effi X,Y ðÞ ¼
Effi X ðÞ   Effi X+Y ðÞ ½ 
Effi X ðÞ
Using this estimator, a good competitor will have a
C_Efﬁ value close to 1 and for a poor competitor, the
value will be 0.
Gel electrophoresis
Gel electrophoresis to validate hit compounds was per-
formed as previously described (23).
RESULTS
The test principles
Several ﬂuorescence based tests for G4 ligands have been
previously reported (25–28). These tests can be classiﬁed
into two categories: (i) stabilization of a G4 by a ligand
followed by FRET melting and (ii) ﬂuorescent ligand dis-
placement by a G4 ligand. Both tests are designed to
identify G4 ligand in the context of a simple equilibrium
between a single-strand and a quadruplex. In our system,
we wanted to identify G4 ligands which could also work in
a duplex–quadruplex equilibrium context, which may be
seen as more physiologically relevant, as it represents a
common situation for DNA or RNA G-rich sequences.
This test is inspired by previous report using ﬂuorescence
to follow DNA duplex–quadruplex competition (29,30). A
similar test using scintillation proximity signal has been
used for high-throughput identiﬁcation of G4 ligands
(31), but this scintillation proximity assay is not easy to
set up in a laboratory and this was a ‘turn off’ test,
meaning that the presence of a quadruplex ligand would
decrease the signal detected. The method combines two
short oligos mimicking the sequence around the P1
helix. Using a full length (451nt) RNA with dual labelling
is impossible here: the test is intermolecular, and a con-
formational change cannot be evidenced in a routine assay
with hTERC.
For convenience, we choose to favour ﬂuorescence de-
tection and in order to built a ‘turn on’ system, we choose
to combine a ﬂuorescent strand with a complementary
strand bearing a quencher. In this system (Figure 1A),
the duplex form is associated with a low-ﬂuorescence
signal, and the quadruplex with a high-ﬂuorescence
signal. Furthermore, because of the well-known
quenching properties of guanines and the possible
quenching of the ﬂuorescence by the ligand bound to the
G4, we decided to insert the ﬂuorescent reporter (FAM)
on the non G-rich strand (F22).
In order to demonstrate that P1-helix formation inhib-
ition was related to G4 formation by the G-rich strand
(37Q), we built a control system bearing G to A substitu-
tions in eight positions within the ﬁrst 32nt of the
sequence (37Qm32). A bone ﬁde G4 ligand should not
be able to prevent duplex annealing for this system
(Figure 1B).
Setting up the test conditions and parameters
Salt conditions. We chose to work at a medium ionic
strength with a total monocation concentration around
100mM. Playing with lithium and potassium concentra-
tions allowed us to modulate G4 stability while keeping
duplex formation relatively unaffected. Following our
previous observation regarding duplex–quadruplex com-
petition on the same system (23), we ﬁrst needed to deﬁne
KCl–LiCl concentrations that allow full duplex formation
in the absence of ligand, but still allow quadruplex forma-
tion of the G-rich strand in absence of its complementary
sequence as follows.
(i) Working in the absence of KCl allows nearly
complete duplex formation but prevent any
quadruplex formation on this system at 37 C even
in the presence of the ligand 360A that we identiﬁed
in our previous work (23).
(ii) Using 10mM KCl (with 90mM LiCl) reduces
duplex formation with the ﬂuorescent system by
30% compared to the result obtained with gel elec-
trophoresis (Supplementary Figure S2).
(iii) On the other hand, using 1mM KCl (supplemented
with 99mM LiCl) leads to a duplex formation com-
parable to the one obtained in 100mM LiCl while
maintaining the ability to inhibit duplex formation
with 360A.
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all further experiments.
Oligonucleotide concentrations. Fluorescence titrations
were performed to determine the practical concentrations
of the ﬂuorescent and quencher oligonucleotides with the
following constraints:
(i) ﬂuorescence signal from the duplex state and the
single-stranded state of the ﬂuorescent oligonucleo-
tide should be above background for ﬂuorescence
detection with either the qPCR machine and the
ﬂuorescent scanner;
(ii) concentrations should be well above duplex dissoci-
ation constant (Kd) to allow complete duplex for-
mation and
(iii) quencher oligonucleotide concentration (37Q)
should be as low as possible to allow easy ligand
titration; and
(iv) quencher oligonucleotide concentration (37Q)
should be equal or higher than the concentration
of the ﬂuorescent oligonucleotide F22.
Titrations were performed with three concentrations of
the ﬂuorescent oligonucleotide (F22) (20, 50 and
100nM) and concentrations of the quencher oligonucleo-
tides (37Q) ranking 0–40, 0–100 and 0–200nM, respect-
ively. These titrations showed that the ﬂuorescent signal
with 20nM of F22 with an excess of 37Q was too close to
background level while titrations with 50 and 100nM were
qualitatively acceptable. In the three cases, concentration
ranges were well above the apparent Kd for duplex forma-
tion that we determined to be in the range of 1–2nM by
ﬁtting the titration data (data not shown). Thus, to limit
G-rich oligonucleotide concentration, we choose to set the
F22 and 37Q concentration to 50 and 75nM, respectively.
Ligand concentration. In our previous work based on gel
electrophoresis (23), we determined that 360A was active
at 1 and 2mM. Preliminary results with 360A on the ﬂuor-
escent system conﬁrmed that this ligand was still active
under conditions of this new test at 1 and 2mM, but
partial quenching of the single-stranded ﬂuorescence was
observed at 2mM of 360A. This led us to choose 1mMa s
the reference concentration for screening purposes.
Screen results
In parallel to setting up and validation experiments with
360A, a few reference compounds have been tested: 12459
(32), PhenDC3 (33) and BRACO19 (34) (Figure 2). These
preliminary experiments demonstrated that PhenDC3 was
a better G4hTERC ligand than 360A and did not quench
the ﬂuorescence of the single strand up to 2mM. We there-
fore decide to use this ligand as our ‘standard’ with the
aim to identify ligand that would be at least as potent as
PhenDC3.
Using a 96-wells plate format, we performed >790 in-
dependent readings corresponding to 173 independent
chemical references and 169 different molecules. Test
quality was assessed using Z0 factor calculation for each
plate. This estimator was routinely in the 0.7–0.9 range,
meaning that the data extracted from these plate are of
very good quality (24). In some experiments, this indicator
fell in the 0.4–0.5 range indicating medium quality data
for this plate. This quality factor was taken into account
to deﬁne the ‘Hit threshold’ (see below).
Every plate used for the screening contains the standard
PhenDC3 to evaluate the test robustness. Under these
conditions, our reference compound PhenDC3 presented
an Efﬁ of 0.77±0.14. For a positive hit, we decided to ﬁx
an arbitrary threshold value of 0.5 for Efﬁ. For a typical
high-quality plate (Z0 >0.7), this corresponds to a signal
of >12 SD above the signal of a negative control. Even for
a medium quality plate (0.4<Z0  0.7), this threshold cor-
responds to a hit signal of >5 SD above the signal of a
negative control. For good quality data set (Z0 >0.7), we
also deﬁne a secondary threshold for medium quality hit
with an threshold Efﬁ value down to 0.4, allowing us to
identify more hits, including positive controls from
the setting up experiment (12459 and 360A). However,
this low-threshold value cannot be used for medium
quality data set as it leads to non-reproducible
Figure 1. Principle of the assay. In the presence of a bona ﬁde quadruplex ligand, duplex formation is inhibited in the F22+37Q system (quadruplex
prone, A) and thus ﬂuorescence of the F22 is high (not quenched) whereas duplex formation is unperturbed on the mutated system (F22m+37Qm32,
non-quadruplex prone, B) and thus F22m ﬂuorescence is low (quenched).
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to molecules with Efﬁ>0.5 and medium hits to molecules
with 0.5 Efﬁ>0.4. Figure 3 and Supplementary Figure
S3 illustrate a typical result. This experiment was of good
quality on the basis of the Z0 factor (0.92) and thus good
(red background) and medium (orange background) hits
were taken into account. All good hit molecules as deﬁned
by their Efﬁ values are associated with a high-ﬂuorescence
intensity (dark blue, see well 2E, 3D, 4G, 8B, 9G, 10C and
10F for examples) whereas non hit molecules present a
low-ﬂuorescence intensity (red–yellow, see well 2C, 6H,
10H and 11H). For some hits, a clear discrepancy is
observed between Efﬁ values and ﬂuorescence images
(see well 2A, 9D and 11A for extreme examples). With
the aim of an unbiaised hit determination, all hit judged
by their Efﬁ values were kept but full renaturation proﬁles
(Supplementary Figure S3A) are usefull to identify poten-
tial artefacts.
Using these threshold values, we identify 10 molecules
as good hits (307A, 832A, BipyDC3, BipyDC6, HB167,
HB173, L2G2, L2H2, PhenDC3, PhenDC6), and 12 as
medium hits (12459, 115405, 360A, BMVC, BOQ1,
HB165, HB282, ET101, ET106, MMQ15, MMQ16,
S1T1-7) in this ﬁrst instance screen. These molecules
were then subject to validation tests.
G4 mechanism validation
In order to validate potential hit, experiments were repro-
duce using in parallel the wild-type system (F22+37Q)
and a mutated system unable to form any G4
(F22m+37Qm32). We also included in this test setup
the free ﬂuorescent oligonucleotides F22 and F22m to
assess for any direct effect of the ligand on these
oligonucleotides. At this validation step, we decide to
include ‘borderline’ and negative molecules as a mean to
validate data from the ﬁrst instance screen, and thus 30
molecules were tested. Three classes of results are
expected:
(i) Class A molecules that are efﬁcient on F22+37Q
and not on F22m+37Qm32 (‘true hits’).
(ii) Class B molecules efﬁcient on both systems
(‘non-speciﬁc hits’) and
(iii) Class C molecules not efﬁcient on the F22+37Q
system (‘false positives’) (Table 1).
From this classiﬁcation, eight molecules come out as
‘good hits’ using a G4 mechanism to prevent P1 helix
formation (307A, 832A, BipyDC3, BipyDC6, L2G2,
L2H2, PhenDC3 and PhenDC6) and three molecules
as G4-related ‘medium hits’ (115405, 12459, 360A). The
existence of a non-speciﬁc-related mechanism could not
be evidenced with any of the selected molecules.
Other compounds have been excluded on the basis of
reproducibility issues (BMVC, BOQ1, ET101, ET106,
HB165, HB167, HB173, HB282, MMQ15,
MMQ16, S1T1-7) and further studies would be required
to validate or invalidate these hits and decipher
experimental noise from molecules stability/solubility
issues.
Data obtained with the single-stranded oligonucleotides
also illustrate two possible artefacts: ﬂuorescence
quenching of the single-stranded oligonucleotides
Figure 2. Proof of principle. Top: post-annealing ﬂuorescence reading of a set-up plate with duplicate of control (H2O, DMSO, 0.05%) and test
molecules (PhenDC3, 360A, 12459 and BRACO19 at 1mM). Lane A, F22 alone; B, F22+37Q; C, F22m; D, F22m+37Qm32. Fluorescence
quenching by the ligand is visible for 12459 and 360A to a lesser extend (A9–10, A7–8, C9–10, C7–8). High ﬂuorescence in lane B correspond to
molecule that prevent annealing of F22 on 37Q (B5–10) and the low ﬂuorescence in the corresponding row in lane D conﬁrms a quadruplex-related
mechanism. Annealing has been perfomed in a real-time thermal cycler and ﬂuorescence annealing proﬁle analysis results in comparable conclusion.
Bottom: formulae of the molecules used in this experiment.
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cence interference in the case of ﬂuorescent ligands
(DOCB and RHPS4). The ﬁrst type of artefact was not
detrimental as the extent of ﬂuorescent quenching was
low. Concerning the second type, the Efﬁ parameter cal-
culation was still valid for RHPS4 as the ﬂuorescence from
the single stranded and the duplex state are both shifted in
the same extend to higher values (Supplementary Figure
S4). On the other hand, the ﬂuorescence properties of
DOCB prevent any reliable Efﬁ calculation, but using
the full annealing proﬁle for the wild type and the
mutated system reveals no P1 helix formation inhibition
(Supplementary Figure S4) allowing us to exclude this
compound.
Figure 3. Efﬁ and post-annealing ﬂuorescence imaging of a typical plate. Each cell correspond to a well of a 96-wells plate used and ﬂuorescence
image of each well has been inserted in each cell between the content of the well and the corresponding Efﬁ value. In this experiment, column 1
contains the ﬂuorescent oligonucleotide F22 alone (line A–D) or in the presence of the control compound PhenDC3 (line E–H). Similarely, column 12
contains the duplex system F22+37Q alone (line A–D) or in the presence of PhenDC3 (line E–H). Lines A–D of these two columns were used for
Efﬁ and Z0 factor (0.92 in this experiment) calculation. Efﬁ values of good or medium hits are highlighted in red and orange, respectively. In this
plate, several chemical references correspond to different batches of PhenDC3 (EDL35, DM550 and DM703) and PhenDC6 (EDL39, DM551 and
DM704). Also note that BipyDC3 and BipyDC6 correspond to the chemical reference EDL93 and EDL95 respectively.
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+ concentration in
the annealing buffer as mentioned in the test setting up
section. Fourteen molecules were tested under these
conditions. No molecule was able to prevent P1 helix
formation in the absence of K
+ (LiCl 100mM). On the
other hand, results with higher K
+ content (KCl
10mM/LiCl 90mM) conﬁrm a G4-related mechanism
for all the class A molecules tested (all the medium or
good hits become good hits) and also revealed that some
non-hits molecule in low KCl become medium or good
hits (BRACO19 and telomestatin). In other words,
increasing potassium concentration decreases the strigency
of the test but conﬁrms that the process studied is K
+-
dependent.
In gel test validation
In order to conﬁrm the results obtained by this ﬂuorescent
assay, seven hit molecules (360A, PhenDC3, PhenDC6,
BipyDC3, BipyDC6, L2G2, L2H2) were tested using the
gel-based system reported in our previous publication
(23). We also included in this test three control molecules:
a true negative control (EDL21) and two molecules that
are efﬁcient only with higher K
+content (telomestatin and
BRACO19). With a higher KCl content (KCl 10mM/LiCl
90mM), we were able to reproduce P1 helix formation
inhibition with all the hit molecules. According to this
test (Supplementary Figure S5A), the molecules can be
split into the following categories regarding P1 helix for-
mation inhibition:
(i) medium: 360A, BipyDC3, BipyDC6;
(ii) good: PhenDC3, PhenDC6, L2G2, L2H2; and
(iii) inactive or weak: results with the control molecules
(EDL21, BRACO19, Telomestatin) are in agree-
ment with the ﬂuorescent test with 10mM KCl:
EDL21 and BRACO19 are not active and the
telomestatin seems slightly less efﬁcient than the
medium hits.
Using the mutated system, that we also published previ-
ously, we conﬁrm that none of these molecules could
prevent the formation of the mutated (non-G4-prone) P1
helix (Supplementary Figure S5B). Under more stringent
conditions (lower KCl content), which are closer to the
ﬂuorescent test conditions, only the PhenDC derivatives
are able to prevent P1 helix formation on the G4-prone
system and still no ligand appears efﬁcient on the non
G4-prone system (Supplementary Figure S5C and D).
This result conﬁrms the PhenDC derivatives as very efﬁ-
cient and speciﬁc molecules to prevent P1 helix formation
on a G4-prone system.
Thus, the results obtained with this gel test with 10mM
KCl are qualitatively comparable to the results from the
ﬂuorescence test with 1mM KCl. Other good hits from the
ﬂuorescent test (L2H2, L2G2, BipyDC3 and BipyDC6)
were not as efﬁcient with this in gel test with KCl 1mM.
This difference could be related to the non-equilibrium
state of the sample during the electrophoresis (partial dis-
placement of the molecule with a lower residency time
upon loading in the gel followed by a duplex renaturation
in the presence of sucrose in the well), arguing in favor of
the ﬂuorescence test.
Speciﬁcity proﬁles
Using the ﬂuorescent test, we also managed to obtain spe-
ciﬁcity proﬁles for some ligands. Similarly to what has
been done with FRET-melting experiments (35), we
evaluated the efﬁcacy of some ligands in the presence of
an excess of various non-ﬂuorescently labelled competitor.
If the ligand has some afﬁnity for the competitor, this later
should trap the ligand and hinder its action of preventing
P1 helix formation (Figure 4A). Two set of competition
experiments were performed, using either a short list of 7
competitors on 11 ligands (good or medium hits) or a
longer list of 21 competitors on PhenDC3, PhenDC6
and L2H2 (Supplementary Table S1). Competition experi-
ments were performed at 1 and 10mM of competitor,
keeping the ligand concentration at 1mM and KCl at
1mM. Control experiments performed in the absence of
ligand conﬁrmed that the competitors used here did not
interfere with the reporter duplex formation (data not
shown).
Competition results can be analyzed using ﬁve classes of
competitors: single-stranded (ss) DNA or RNA,
double-stranded (ds) DNA, G4DNA and G4RNA.
SsDNA, ssRNA or dsDNA competitors had very little
effect on most of the ligands (with the exception of
115405). Ligand efﬁcacies were generaly reduced in
presence of 10mM of G4 competitor, which conﬁrms the
preference of these ligands for G4 structures. 12459, L2G2
and L2H2 were the least affected by G4 competitor, sug-
gesting that these ligands exhibit the highest speciﬁcity for
Table 1. Results summary
Reproductibility ss
binding
mutant
system
binding
Efﬁ
Li100
Efﬁ
K1
Efﬁ
K10
Medium hits
12459 + + – – + + +
115405 + + – – + + +
360A + – – – + + +
Good hits
307A + – – – + +n d
832A + – – – + +n d
BiPyDC3 + – – – + ++ +
BiPyDC6 + – – – + ++ +
L2G2 + – – – + ++ +
L2H2 + – – – + ++ +
PhenDC3 + – – – + ++ +
PhenDC6 + + – – + ++ +
Negative
AGVI191 + nd – – – –
BRACO19 + nd – – – +
DOCB + * – – nd nd
RHPS4 + * – – nd nd
Telomestatin – – – – – + +
Reproducibility: +, good or medium hit in all experiments. Ss binding:
+, low-ﬂuorescence intensity of F22 alone in the presence of the
compound, *, ﬂuorescent molecule (see main text). Mutant system
binding: –, the compound was not able to prevent the annealing with
the mutated system F22m+37Qm32. Efﬁ (Li100, K1, K10): –, below
0.4, +; between 0.4 and 0.5; + +, above 0.5. nd, not determined.
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of ligand allow a more detailed proﬁling, and indicate
some preferences for G4 RNA versus G4DNA for
PhenDC6, 832A, 307A, BipyDC6, L2G2 and L2H2, and
no marked preference for PhenDC3 and BipyDC3
(Supplementary Figure S6).
Using a larger panel of quadruplex competitors allowed
us to separate the G4 DNA class into telomeric G4DNA,
promoter G4DNA and other G4. Using these subclasses
for PhenDC3, PhenDC6 and L2H2 enable us to propose
that L2H2 and PhenDC6 have a preference for G4RNA
(clearly visible at 1mM of competitor) whereas PhenDC3
has no marked preference (Figure 4C) but a larger number
of G4RNA sequences should be used in order to draw a
more detailled conclusion.
We have also tested the unusual G4DNA formed by the
(sub)telomeric sequence variant AGGG(CTAGGG)3 (36)
as competitor for L2H2, PhenDC3 and PhenDC6. This
G4 was a very inefﬁcient competitor (Supplementary
Figure S6). In this particular quadruplex, only two G
quartets are formed and a GCGC quartet at one end
and a GC pair at the other end cap them. In this
context, terminal stacking by the ligand is expected to be
disfavoured on both sides and thus this further argue for a
terminal stacking type of interaction of these ligands with
the other more classical G4.
DISCUSSION
Critical parameters
This ﬂuorescent test allowed us to identify 11 ligands that
prevent the hybridization of a couple of oligonucleotides
mimicking the P1 helix of hTERC.
The concentration of cations-especially K
+-is a critical
parameter in this test as it directly affects the amount of
duplex formed in the absence of ligand. When comparing
ligand efﬁcacy under different cation conditions, errone-
ous conclusion can be drawn if care is not taken for the
calculation. One should always compare the amount of
Figure 4. Selectivity proﬁle. (A) Principle of the selectivity test. (B) Chemical formulae of the best hits. C_Efﬁ values for the three best hits (1mM)
challenged with 21 differents competitors of six types (ssDNA, dsDNA, ssRNA, telomeric G4DNA, promoter type G4DNA, G4RNA) at 1 and
10mM.
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cation condition to the amount of duplex formed in the
absence of ligand and under cation conditions that allow
quasi-complete duplex formation (LiCl 100mM or KCl
1mM/LiCl 99mM). If KCl 10mM/LiCl 90mM condi-
tions are used to evaluate ligand efﬁcacy, Efﬁ would be
overestimated as less duplex is formed even in the absence
of ligand. Similar care should be taken for C_Efﬁ calcu-
lation as this calculation is derived from Efﬁ calculation.
These parameters are thus not appropriate for external
parameters evaluation even if they remain robust to
compare ligands or competitors under the same cation
condition. If a wide range of external parameters are to
be tested, NF would be more appropriate, but with NF,
comparison between the G4-forming system and the
non-G4-forming system are not possible as the tempera-
ture dependency of ﬂuorescence properties of the duplexes
and the ‘open’ form are not comparable for the two
systems.
Screening test?
Using the low threshold to identify what we called
medium and good hits leads to a high-success rate for
the ﬁrst intention screen (22/169). This 13% success rate
reﬂects the fact that the original library was strongly
biased towards G4 ligands and in particular telomeric
G4 DNA ligands. The validation tests indicate that the
majority (9/12) of the medium hits were false positives
whereas the majority of the good hits (8/10) were
validated. Therefore, setting the threshold to 0.5 lead to
more robust results with an acceptable success rate (6%
for the ﬁrst intention screen and 5% after validation).
Using a non-biased library should allow a lower success
rate compatible with high throughput approaches.
In the actual conﬁguration of the test, incubation of the
ligand in the presence of the preformed duplex would
appear unnecessary as we failed to identify any ligand
able to restore ﬂuorescence on this substrate. Indeed for
competition experiments, this ﬁrst step of the protocol is
not used but with the objective to identify ligand that
could affect a preassembled telomerase, we propose to
keep this step for genuine library screening.
In order to identify bone ﬁde G4hTERC ligands and
rule out general G4 ligands, non-labelled competitors
could be added even in the primary screen. Using either
a mixture of competitors or a competitor that could mimic
both promoter and telomeric type of quadruplexes [like
GTERT060 (22)] could be interesting.
Comparision with FRET-melting assays for G4 ligands
There are important differences between the ‘traditional’
FRET-melting assay we developped a decade ago (25,37)
and this assays:
(i) instead of looking at a single-strand—quadruplex
transition, we are studying a duplex—quadruplex
competition. This may be seen as more physiologic-
ally relevant, as it represents a common situation
for DNA or RNA G-rich sequences, in which
local unwiding of the double-helix is required to
allow G4 formation.
(ii) One can naturally adapt this assay to ‘almost any
DNA or RNA quadruplex’ forming sequence
(except perhaps for the most stable ones) provided
that the Li
+/K
+ balance is adjusted to allow a
duplex formation that can be ‘easily challenged’ by
a quadruplex ligand. The hTERC system presented
here was chosen as RNA is less often studied and
competition with P1 helix formation is biologically
relevant.
(iii) The test is based on a ‘bi-molecular’ interaction,
rather than on a conformational change of an intra-
molecular quadruplex. This is an important point,
as it will allow further developments with methods
adapted for true HTS format, such as such as
alphascreen or TR-FRET.
(iv) The test allows the design of a ‘control duplex’
system, with mutated C- and G-rich strand that
retain equivalent duplex potential but lose
quadruplex-forming ability. This control is essential
to avoid false positive interfering with the assay. A
similar control cannot be implemented in the
previous assays.
(v) A ‘variety of competitors’ may be tested in this
assay. We acknowledge that different unlabelled se-
quences could be tested in the FRET-melting assay,
but a major limitation was that the stability of the
competitor had to be signiﬁcantly larger than the
one the labelled quadruplex (otherwise, if the com-
petitor melts at a lower temperature, it cannot act as
a duplex or quadruplex competitor when the
labelled sequence starts to unfold). This is not a
problem here: one does not need to worry about
comparing stabilities of the different structures; all
that is needed is that the competitor folds at the
temperature of the assay. The only limitation is
that the competitor should not be capable of hy-
bridization with the complementary C-rich strand.
But this is a moderate limitation as compared to the
ones we face with FRET melting. We indeed tested
an unprecedented number of competitors in this MS
(Figure 4 and Supplementary Figure S6).
(vi) In principle, one may design an ‘isothermal’ version
of this approach (but this requires adding the dif-
ferent components of the reaction in a precise order:
the C-rich complementary strand being added last).
This is a fundamental difference with a FRET-
melting assay, which does provide semi-quantitative
information on the stabilization efﬁciency, but
requires scanning a wide temperature range. In
this assay, one could restrict the analysis to a
single-physiological temperature (37 C): this is an
important condition to design an assay with a
high-throughput potential.
The two assays are actually complementary, as the assay
presented here can be adapted to high-throughput (either
to test many ligands or many competitors). On the other
hand, FRET melting may provide semi-quantitative infor-
mation which is more difﬁcult to derive from this method.
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activity of G4 nucleases. In this case, thermal denaturation
is likely to affect the protein activity and thus protein
activity should occur in the ﬁrst step of the annealing pro-
cedure, meaning that the complementary strand should be
added after the denaturation step.
hTERC targeting?
With this test, we identiﬁed ligands that may prevent P1
helix formation in hTERC through a G4 mechanism. The
ultimate goal is to ﬁnd compounds that bind to this
full-length RNA and induce a conformational change,
but the screening assay developped here cannot be
directly transposed to a much larger RNA. Interference
with P1-helix formation remains to be demonstrated on
the fully folded hTERC embedded in an active telomerase
complex. The telomerase substrate is also able to form G4
structures, and thus in the absence of fully speciﬁc ligand
targeting the G4 of hTERC, evaluation of the activity of
these ligands on telomerase activity would require to
deconvoluate G4-related effect on hTERC from the
effect on the telomeric substrate. This will require the
design and characterization of mutant of hTERC with
mutations either in the G4-prone sequence and/or in the
template of hTERC.
Furthermore the biological consequences of P1 disrup-
tion in hTERC remain to be tested. P1 disruption could
either alter the template boundary deﬁnition (38) and thus
prevent processive addition of the telomeric repeat or lead
the incorporation of mutated repeat (39) but it could also
affect the global folding of hTERC in the telomerase
complex by altering long distance interaction (40,41) or
ﬁnally it could also affect proper telomerase assembly of
localization (42).
Up to now, none of articles analyzing the effects of G4
ligands on telomerase activity took into account the pos-
sibility that these ligands could also act by binding on the
RNA component of telomerase: their effects on telomer-
ase was generally attributed to a binding on the telomeric
DNA substrate. In our previous publication (23), we
showed that a novel quadruplex-prone target may be
involved in these effects. In this article, we also showed
that many G4 ligands used to target telomeric G4 can also
bind to hTERC. In order to deconvoluate these
mechanisms and validate the intended P1 helix-related
mechanism, one will need to ﬁnd a ligand truly speciﬁc
for hTERC quadruplex, with no binding to the human
telomeric motif. The assay developped here allows for
such screening. So far, even if some ligands exhibit a pref-
erence for hTERC over telomeric DNA, the differential
afﬁnity is not sufﬁcient. However, as discussed above, our
method will allow the screening of much larger libraries to
ﬁnd promising compounds. These questions remain to be
tested and the quest for a G4 ligand speciﬁc for a given G4
folding, sequence and chemistry is the next challenge for
chemists in the ﬁeld.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We wish to thank all the chemists for providing ligands
(‘Materials and Methods’ section), D. Morgan, J. Gros,
A. De Cian and A. Gue ´ din for technical advices and dis-
cussions, A. Ceccaldi for the Z0 factor, C. Guetta and
E. Largy for preparing the compounds plate.
FUNDING
INSERM (to J.-L.M.); ARC (to J.-L.M.); CNRS-MNHN
(to J.-L.M.); ‘Fondation pour la Recherche Me ´ dicale,
Re ´ gion Aquitaine’ (to J.-L.M.); CNRS-PIR (to J.L.M.);
ANR-09-Blanc-0355 (to J.-L.M.). Funding for open
access charge: INSERM U565, CNRS-MNHN
UMR7196; Museum National d’Histoire Naturelle, 43
rue Cuvier, 75005 Paris, France.
Conﬂict of interest statement. None declared.
REFERENCES
1. Gellert,M., Lipsett,M.N. and Davies,D.R. (1962) Helix formation
by guanylic acid. Proc. Natl Acad. Sci. USA, 48, 2013–2018.
2. Lipps,H.J. and Rhodes,D. (2009) G-quadruplex structures: in vivo
evidence and function. Trends Cell Biol., 19, 414–422.
3. Maizels,N. (2006) Dynamic roles for G4 DNA in the biology of
eukaryotic cells. Nat. Struct. Mol. Biol., 13, 1055–1059.
4. Paeschke,K., Simonsson,T., Postberg,J., Rhodes,D. and Lipps,H.
(2005) Telomere end-binding proteins control the formation of
G-quadruplex DNA structures in vivo. Nat. Struct. Mol. Biol.,
12, 847–854.
5. Duquette,M.L., Handa,P., Vincent,J.A., Taylor,A.F. and
Maizels,N. (2004) Intracellular transcription of G-rich DNAs
induces formation of G-loops, novel structures containing G4
DNA. Genes Dev., 18, 1618–1629.
6. Cahoon,L.A. and Seifert,H.S. (2009) An alternative DNA
structure is necessary for pilin antigenic variation in Neisseria
gonorrhoeae. Science, 325, 764–767.
7. Gomez,D., Lemarteleur,T., Lacroix,L., Mailliet,P., Mergny,J.L.
and Riou,J.F. (2004) Telomerase downregulation induced by the
G-quadruplex ligand 12459 in A549 cells is mediated by hTERT
RNA alternative splicing. Nucleic Acids Res., 32, 371–379.
8. Kumari,S., Bugaut,A., Huppert,J. and Balasubramanian,S. (2007)
An RNA G-quadruplex in the 50 UTR of the NRAS
proto-oncogene modulates translation. Nat. Chem. Biol., 3,
218–221.
9. Wieland,M. and Hartig,J.S. (2007) RNA quadruplex-based
modulation of gene expression. Chem. Biol., 14, 757–763.
10. Randall,A. and Grifﬁth,J.D. (2009) Structure of long telomeric
RNA transcripts: the G-rich RNA forms a compact repeating
structure containing G-quartets. J. Biol. Chem., 284, 13980–13986.
11. Zahler,A.M., Williamson,J.R., Cech,T.R. and Prescott,D.M.
(1991) Inhibition of telomerase by G-quartet DNA structures.
Nature, 350, 718–720.
12. Sun,D., Thompson,B., Cathers,B.E., Salazar,M., Kerwin,S.M.,
Trent,J.O., Jenkins,T.C., Neidle,S. and Hurley,L.H. (1997)
Inhibition of human telomerase by a G-quadruplex-interactive
compound. J. Med. Chem., 40, 2113–2116.
13. Zhang,M.L., Tong,X.J., Fu,X.H., Zhou,B.O., Wang,J., Liao,X.H.,
Li,Q.J., Shen,N., Ding,J. and Zhou,J.Q. (2010) Yeast telomerase
subunit Est1p has guanine quadruplex-promoting activity that is
required for telomere elongation. Nat. Struct. Mol. Biol., 17,
202–209.
14. Gomez,D., O’Donohue,M.F., Wenner,T., Douarre,C., Macadre ´ ,J.,
Koebel,P., Giraud-Panis,M.J., Kaplan,H., Kolkes,A., Shin-ya,K.
et al. (2006) The G-quadruplex ligand telomestatin inhibits POT1
binding to telomeric sequences in vitro and induces GFP-POT1
dissociation from telomeres in human cells. Cancer Res., 66,
6908–6912.
e21 Nucleic Acids Research, 2011,Vol. 39,No. 4 PAGE 10 OF 1115. De Cian,A., Cristofari,G., Reichenbach,P., De Lemos,E.,
Monchaud,D., Teulade-Fichou,M.P., Shin-ya,K., Lacroix,L.,
Lingner,J. and Mergny,L. (2007) Reevaluation of telomerase
inhibition by quadruplex ligands and their mechanisms of action.
Proc. Natl Acad. Sci. USA, 104, 17347–17352.
16. Sfeir,A., Kosiyatrakul,S.T., Hockemeyer,D., MacRae,S.L.,
Karlseder,J., Schildkraut,C.L. and de Lange,T. (2009) Mammalian
telomeres resemble fragile sites and require TRF1 for efﬁcient
replication. Cell, 138, 90–103.
17. Azzalin,C.M., Reichenbach,P., Khoriauli,L., Giulotto,E. and
Lingner,J. (2007) Telomeric repeat containing RNA and RNA
surveillance factors at mammalian chromosome ends. Science,
318, 798–801.
18. Luke,B. and Lingner,J. (2009) TERRA: telomeric
repeat-containing RNA. EMBO J., 28, 2503–2510.
19. Sacca ` ,B., Lacroix,L. and Mergny,J.L. (2005) The effect of
chemical modiﬁcations on the thermal stability of different
G-quadruplex-forming oligonucleotides. Nucleic Acids Res., 33,
1182–1192.
20. Siddiqui-Jain,A., Grand,C.L., Bearss,D.J. and Hurley,L.H. (2002)
Direct evidence for a G-quadruplex in a promoter region and its
targeting with a small molecule to repress c-MYC transcription.
Proc. Natl Acad. Sci. USA, 99, 11593–11598.
21. Palumbo,S.L., Ebbinghaus,S.W. and Hurley,L.H. (2009)
Formation of a unique end-to-end stacked pair of
G-quadruplexes in the hTERT core promoter with implications
for inhibition of telomerase by G-quadruplex-interactive ligands.
J. Am. Chem. Soc., 131, 10878–10891.
22. Lim,K.W., Lacroix,L., Yue,D.J., Lim,J.K., Lim,J.M. and
Phan,A.T. (2010) Coexistence of two distinct G-quadruplex
conformations in the hTERT promoter. J. Am. Chem. Soc., 132,
12331–12342.
23. Gros,J., Gue ´ din,A., Mergny,J.L. and Lacroix,L. (2008)
G-quadruplex formation interferes with P1 helix formation in the
RNA component of telomerase hTERC. Chembiochem, 9,
2075–2079.
24. Zhang,J.L., Chung,T.D. and Oldenburg,K.R. (1999) A simple
statistical parameter for use in evaluation and validation of high
throughput screening assays. J. Biomol. Screen., 4, 67–73.
25. Mergny,J.L., Lacroix,L., Teulade-Fichou,M.P., Hounsou,C.,
Guittat,L., Hoarau,M., Arimondo,P.B., Vigneron,J.P., Lehn,J.M.,
Riou,J.F. et al. (2001) Telomerase inhibitors based on quadruplex
ligands selected by a ﬂuorescence assay. Proc. Natl Acad. Sci.
USA, 98, 3062–3067.
26. Guyen,B., Schultes,C.M., Hazel,P., Mann,J. and Neidle,S. (2004)
Synthesis and evaluation of analogues of
10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands
and potential inhibitors of the enzyme telomerase. Org. Biomol.
Chem., 2, 981–988.
27. Paramasivan,S. and Bolton,P.H. (2008) Mix and measure
ﬂuorescence screening for selective quadruplex binders. Nucleic
Acids Res., 36, e106.
28. Monchaud,D., Allain,C. and Teulade-Fichou,M. (2006)
Development of a ﬂuorescent intercalator displacement assay
(G4-FID) for establishing quadruplex-DNA afﬁnity and selectivity
of putative ligands. Bioorg. Med. Chem. Lett., 16, 4842–4845.
29. Li,J.W.J. and Tan,W.H. (2002) A single DNA molecule
nanomotor. Nano Lett., 2, 315–318.
30. Alberti,P. and Mergny,J.L. (2003) DNA duplex-quadruplex
exchange as the basis for a nanomolecular machine. Proc. Natl
Acad. Sci. USA, 100, 1569–1573.
31. Guittat,L., Lacroix,L., Gomez,D., Arimondo,P.B., De Cian,A.,
Pennarun,G., Amrane,S., Alberti,P., Lemarteleur,T., Aouali,N.
et al. (2004) In Parisi,V., Valeria De Fonzo,V. and Alufﬁ-
Pentini,F. (eds), Dynamical Genetics. Research Signpost, Kerala,
India, pp. 199–236.
32. Gomez,D., Aouali,N., London ˜ o-Vallejo,A., Lacroix,L., Me ´ gnin-
Chanet,F., Lemarteleur,T., Douarre,C., Shin-ya,K., Mailliet,P.,
Trentesaux,C. et al. (2003) Resistance to the short term
antiproliferative activity of the G-quadruplex ligand 12459 is
associated with telomerase overexpression and telomere capping
alteration. J. Biol. Chem., 278, 50554–50562.
33. De Cian,A., Delemos,E., Mergny,J.L., Teulade-Fichou,M.P. and
Monchaud,D. (2007) Highly efﬁcient G-quadruplex recognition by
bisquinolinium compounds. J. Am. Chem. Soc., 129, 1856–1857.
34. Gowan,S.M., Harrison,J.R., Patterson,L., Valenti,M., Read,M.A.,
Neidle,S. and Kelland,L.R. (2002) A G-quadruplex-interactive
potent small-molecule inhibitor of telomerase exhibiting in vitro
and in vivo antitumor activity. Mol. Pharmacol., 61, 1154–1162.
35. De Cian,A., Guittat,L., Kaiser,M., Sacca ` ,B., Amrane,S.,
Bourdoncle,A., Alberti,P., Teulade-Fichou,M., Lacroix,L. and
Mergny,J.L. (2007) Fluorescence-based melting assays for
studying quadruplex ligands. Methods, 42, 183–195.
36. Lim,K.W., Alberti,P., Guedin,A., Lacroix,L., Riou,J.F.,
Royle,N.J., Mergny,J.L. and Phan,A.T. (2009) Sequence variant
(CTAGGG)n in the human telomere favors a G-quadruplex
structure containing a G.C.G.C tetrad. Nucleic Acids Res., 37,
6239–6248.
37. Mergny,J.L. and Maurizot,J.C. (2001) Fluorescence resonance
energy transfer as a probe for G-quartet formation by a telomeric
repeat. Chem. Bio. Chem., 2, 124–132.
38. Chen,J.L. and Greider,C. (2003) Template boundary deﬁnition in
mammalian telomerase. Genes Dev., 17, 2747–2752.
39. Kim,M.M., Rivera,M.A., Botchkina,I.L., Shalaby,R., Thor,A.D.
and Blackburn,E.H. (2001) A low threshold level of expression of
mutant-template telomerase RNA inhibits human tumor cell
proliferation. Proc. Natl Acad. Sci. USA, 98, 7982–7987.
40. Ueda,C.T. and Roberts,R.W. (2004) Analysis of a long-range
interaction between conserved domains of human telomerase
RNA. RNA, 10, 139–147.
41. Li,X., Nishizuka,H., Tsutsumi,K., Imai,Y., Kurihara,Y. and
Uesugi,S. (2007) Structure, interactions and effects on activity of
the 50-terminal region of human telomerase RNA. J. Biochem.,
141, 755–765.
42. Cristofari,G., Adolf,E., Reichenbach,P., Sikora,K., Terns,R.M.,
Terns,M.P. and Lingner,J. (2007) Human telomerase RNA
accumulation in Cajal bodies facilitates telomerase
recruitment to telomeres and telomere elongation. Mol. Cell, 27,
882–889.
PAGE 11 OF 11 Nucleic AcidsResearch, 2011, Vol.39,No. 4 e21